Clinical and ocular abnormalities in DEGCAGS syndrome-Developmental delay with gastrointestinal, cardiovascular,

Syed M Ali1,2,3, Dua A AlMasri3, Carlos E Prada4,5

  • 1Moorfields Eye Hospital Abu-Dhabi, Abu Dhabi, UAE.

PubMed

Insights

This report details a novel ZNF699 gene variant causing Developmental Delay with Gastrointestinal, Cardiovascular, Genitourinary, and Skeletal Abnormalities (DEGCAGS) syndrome. The study highlights previously undescribed visual system abnormalities in this rare genetic disorder.

Area of Science:

  • Genetics
  • Pediatrics
  • Ophthalmology

Background:

  • Developmental Delay with Gastrointestinal, Cardiovascular, Genitourinary, and Skeletal Abnormalities (DEGCAGS) syndrome is a rare genetic disorder.
  • Genetic variations in the ZNF699 gene have been implicated in DEGCAGS syndrome.

Observation:

  • A consanguineous Middle Eastern family presented with a history of a previously affected child with severe hypotonia.
  • The current infant exhibited significant medical issues including hypotonia, dysmorphia, and multi-system abnormalities from birth.
  • The infant was found to have a novel homozygous pathogenic missense variant in the ZNF699 gene.

Findings:

  • The patient was diagnosed with DEGCAGS syndrome due to a homozygous missense variant in the ZNF699 gene.
  • Clinical examination revealed multi-systemic abnormalities, including previously undocumented visual system disorders.
  • This represents the 15th reported case of DEGCAGS syndrome and the first with homozygous ZNF699 missense variants and detailed retinal imaging.

Implications:

  • This case expands the understanding of ZNF699-related DEGCAGS syndrome, particularly regarding ocular manifestations.
  • Identifying novel genetic variants aids in accurate diagnosis and genetic counseling for families with DEGCAGS syndrome.
  • Further research into ZNF699 function is warranted to elucidate the pathogenesis of DEGCAGS syndrome and associated visual abnormalities.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
165
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
592
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
88